DOSSIER · 13F Holders · Q2 2026
ZBIO 2.5 04/01/32

ZENAS BIOPHARMA INC

12 institutions still hold ZENAS BIOPHARMA INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 98937LAA3·12 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$155M
visible holders
Holders
12
filers reporting
Concentration
27.66%
LINDEN ADVISORS LP #1
top holder share
AI Holders Summary · Q2 2026

12 institutions reported ZBIO 2.5 04/01/32 in Q2 2026. LINDEN ADVISORS LP leads at 27.7% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
LINDEN ADVISORS LP
CIK 0001279396
$43M35.9M0.22%Q2 2026
02
Context Capital Management, LLC
CIK 0001301396
$43M35.8M0.83%Q2 2026
03
CITADEL ADVISORS LLC
CIK 0001423053
$26M21.7M0.00%Q2 2026
04
BRAIDWELL LP
CIK 0001920938
$13M13.0M0.45%Q1 2026
05
JANE STREET GROUP, LLC
CIK 0001595888· Market maker
$10M9.5M0.00%Q1 2026
06
Jefferies Financial Group Inc.
CIK 0000096223
$6M5.0M0.04%Q2 2026
07
CAPSTONE INVESTMENT ADVISORS, LLC
CIK 0001426196
$4M3.5M0.01%Q2 2026
08
Graham Capital Management, L.P.
CIK 0001315421
$3M2.5M0.05%Q2 2026
09
Woodline Partners LP
CIK 0001784547
$3M2.5M0.01%Q2 2026
10
ADVENT CAPITAL MANAGEMENT /DE/
CIK 0001097278
$3M2.4M0.06%Q2 2026
11
AGF MANAGEMENT LTD
CIK 0001003518
$1M1.2M0.01%Q2 2026
12
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
$239K200K0.00%Q2 2026